SUNTEC-GROUP
9.12.2021 06:26:14 CET | Business Wire | Pressemeddelelse
SunTec Business Solutions, verdens førende prisfastsættelses- og faktureringsvirksomhed, meddelte i dag, at virksomheden er blevet valgt af Nordens førende erhvervsbank, SEB, til en koncernomspændende global udrulning og til at automatisere deres næste generation af tilbud-til-fakturering-program. SunTecs pakke med løsninger vil digitalisere bankens salgsproces, fra aftalehåndtering og prisfastsættelse til fakturering.
SEB valgte SunTec som teknologipartner til at hjælpe med at opfylde deres vigtigste strategiske initiativer for at blive førende inden for kundeoplevelser, skabe robusthed og fleksibilitet i banken og øge aktiviteterne for store erhvervs- og finansinstitutioner samt SMV'er.
Olle Durelius, Co-Head Transaction Services hos SEB, fortæller, "Vores ambition er at opgradere vores eksisterende processer, og vi er meget glade for at have indgået et partnerskab med SunTec og starter denne rejse for at forbedre og fremme digitalisering og automatisering. Vi var på udkig efter en løsningsudbyder, der kunne understøtte transformationen af vores aktiviteter. I SunTec fandt vi en ligesindet partner, der kunne hjælpe os med at digitalisere vores salgsproces, sikre hurtigere time-to-market, stoppe indtægtslækager, reducere manuel indgriben og sikre, at vi fakturerer klienterne i overensstemmelse med deres forventninger. Med SunTecs pakke med løsninger og platformen Xelerate vil vi understøtte vores aktiviteter inden for likviditetsstyring samt globale depotydelser og "sub-custody" til en start."
Nanda Kumar, grundlægger og CEO hos SunTec, udtaler, "Vi er meget glade for at have indgået et partnerskab med SEB for at styrke deres position som rådgiver til erhvervsklienter, forbedre driftsmæssig fortræffelighed og sikre digital distribution af deres tilbud. Vores robuste pakke med løsninger udrullet på vores Xelerate-platform vil tilbyde en teknologisk infrastruktur, der er API-venlig, modulopbygget af natur, og som automatiserer deres tilbud til fakturering-livscyklus. Denne aftale er en milepæl for os i Norden og viser, at banker i stigende grad skal gå mod en arkitektur i tre lag og udnytte et intelligent midterlag for at sikre agilitet og kundecentrering."
Om SunTec
SunTec er verdens førende prisfastsættelses- og faktureringsvirksomhed, der skaber værdi for virksomheder via cloudbaserede produkter. Mere end 130 klienter i over 45 lande stoler på, at SunTec kan levere meget personligt tilpassede produkter, tilbud, prisfastsættelse, loyalitetsprogrammer og fakturering for mere end 400 millioner slutkunder. SunTecs produkter er baseret på vores cloud-native og cloud-agnostiske, API first, mikrotjenestebaserede proprietære platform, Xelerate, og leveres på stedet, på privat cloud og som SaaS. SunTec har globale aktiviteter, der omfatter USA, Storbritannien, Tyskland, Forenede Arabiske Emirater, Singapore, Canada, Australien og Indien. Besøg www.suntecgroup.com for at få flere oplysninger, eller send en e-mail til os på marketing@suntecgroup.com .
Originalsprogsudgaven af denne bekendtgørelse er den officielle, autoriserede version. Oversættelserne er kun tænkt som en hjælp og bør sammenholdes med kildesprogsteksten, der som den eneste er juridisk bindende.
Se kildeudgaven på businesswire.com: https://www.businesswire.com/news/home/20211208006173/da/
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Hologic Signs Definitive Agreement to Acquire Reveal Genomics19.10.2026 21:30:00 CEST | Press release
Acquisition would expand Hologic’s oncology diagnostics portfolio to help inform treatment decisions for more women with breast cancer Hologic, a global leader in women’s health, today announced that it has signed a definitive agreement to acquire Reveal Genomics, a precision oncology company based in Barcelona, Spain, that develops advanced genomic diagnostic tests to help personalized cancer treatment, including its HER2DX test to help optimize therapy for patients with HER2-positive breast cancer. Breast cancer remains one of the most significant health challenges women face today. Reveal Genomics’ tests are highly complementary to Hologic’s existing oncology diagnostics, including the Breast Cancer Index® (BCI) test, the guideline-recognized genomic assay to help inform decisions regarding extended endocrine therapy in women with HR+ early-stage breast cancer. The combination of Hologic’s existing testing with Reveal Genomics’ portfolio represents a significant expansion of Hologic
An Active Role in Freshness: ProAmpac Introduces ProActive Intelligence Shelf Protect19.10.2026 21:27:00 CEST | Press release
ProAmpac, a global leader in flexible packaging and material science, introduces ProActive Intelligence™ Shelf Protect (SP) Series, giving food producers a new way to help preserve product quality and reduce costly spoilage. Designed for select meat, seafood, and dairy applications, the technology is FDA- and USDA-compliant for intended uses in fresh beef, fresh pork, cooked sausage, deli meat, fresh salmon, and fresh cheese. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261019305953/en/ Clearshield®-SP Shrink Bag This direct food-contact biotechnology packaging helps reduce microbial growth associated with food spoilage in intended applications, supporting longer shelf life throughout storage and distribution. Shelf Protect’s patented biotechnology is built directly into food-contact packaging film. “For meat processors, every product lost represents an investment in production, packaging, and distribution that goes unreal
Vedanta Ltd Doubles Zinc Capacity in South Africa with US$ 600 Mn investment19.10.2026 19:19:00 CEST | Press release
Vedanta Limited doubled its annual zinc production capacity to 500,000 tonnes1in South Africa through an investment of nearly US$ 600 Mn at Gamsberg (Phase II) at Vedanta Zinc International (VZI). Gamsberg has one of the world’s most significant zinc deposits and is VZI’s flagship zinc mine. Inaugurated by South African President Cyril Ramaphosa and Vedanta Limited Director Priya Agarwal-Hebbar, this expansion marks one of the decade’s largest mining investments in South Africa. It advances Vedanta Limited’s position as the world’s largest2 zinc producer, with a vision of achieving 3 million tonnes of annual production across India and South Africa. Of this, 2 million tonnes are targeted from its subsidiary, Hindustan Zinc Limited the world’s largest integrated zinc producer, while Vedanta Zinc International business aims to contribute 1 million tonnes annually. This expansion strengthens the ZAR 21 Bn (nearly US$ 1.5 Bn) investment commitment Vedanta made at the 2018 South Africa Inve
Unlocking Digital Gold’s US$700bn Opportunity19.10.2026 18:00:00 CEST | Press release
The digital gold market, worth US$45–55bn today, could unlock up to US$700bn in latent demand, according to new research from World Gold Council and Boston Consulting Group. The report points to substantial untapped appetite among retail investors, with nearly nine in ten surveyed saying they would consider digital gold under the right conditions. The US$700bn opportunity represents the report’s estimate of total latent demand that could be released if today’s barriers to adoption were removed, rather than a near-term forecast. The report’s five-year base case sees digital gold growing by around 27% a year to US$160–170bn by 2031. That could rise to US$270–280bn over the same time if more barriers fall faster. Momentum is already building as financial markets undergo a broader digital transformation, bringing tokenised investment products increasingly into the mainstream. Tokenised gold, one segment of the digital gold market alongside vaulted digital gold, has grown fivefold in value
Roquette Brings Broad Portfolio of Excipient Solutions and Technical Expertise to AAPS PharmSci 360 202619.10.2026 16:00:00 CEST | Press release
Roquette, a global leader in plant-based ingredients, excipients and pharmaceutical solutions, will showcase its expansive portfolio of excipients, capsules, coatings, and biopharma solutions at AAPS PharmSci 360 2026. The conference and trade show will take place October 26-28 in New Orleans, Louisiana, USA. At Booth 1100 in the exhibit hall, Roquette’s Health & Pharma Solutions team will share their expertise across controlled-release technologies, hydroxypropyl beta-cyclodextrins, and sustainable formulation approaches, alongside a comprehensive portfolio of innovative solutions designed to address the evolving needs of pharmaceutical developers. “AAPS PharmSci 360 is a key opportunity to share our latest innovations, as well as highlight the breadth and depth of our scientific know-how that helps our customers solve complex formulation challenges,” said Peter Freed, Head of Technical Service & Development North America for Roquette’s Health & Pharma Solutions Business Unit. “From a
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum
